|
Published by: Mintel International Group Ltd.
Published: Apr. 1, 2009
Table of Contents
- Scope and Themes
- What you need to know
- Definition
- Data sources
- Consumer survey data
- Abbreviations and terms
- Abbreviations
- Terms
- Executive Summary
- Sufferers’ trust in pharmacists, openness to fitness and alternative remedies spell opportunity for arthritis industry
- Marketing in the pharmacy aisle
- Arthritis fitness
- Sufferers have alternatives
- Market driven by aging population, obesity epidemic, lack of health insurance
- Half of over-65s have arthritis
- Overweight and obese at higher risk
- Lack of health insurance can impede prevention, worsen symptoms
- Brand qualities
- Biologics battle it out
- Rubs, creams, wraps, and patches vie for patient attention
- OTC remedies that emphasize arthritis will likely attract more sufferers
- Innovations: Creams, functional beverages, potential drugs
- Creams: from balms to wraps, from patches to massage oils
- Functional beverages pinpoint arthritis
- The pharmaceutical pipeline
- Advertising and promotion
- DTC spending down
- Cross-promotion vs. single-purpose ads
- TV ads typically employ “pharmamercial” theme
- The arthritis consumer
- Arthritis sufferers
- Treatment, prevention, and sources
- Attitudes and motivations
- Race and Hispanic origin
- MARKET DRIVERS
- An aging population means higher arthritis incidence
- Juvenile arthritis incidence may increase with growing child population
- Figure 1: Population, by age, 2003-13
- Obesity is a leading contributor to OA
- High incidence of childhood obesity could lead to more adult OA cases
- Figure 2: Prevalence of overweight and obesity among Americans, by gender and age, 1988-94 and 1999-2002
- Health insurance crisis impacts arthritis sufferers
- Figure 3: Number of uninsured, 2001-07
- Organizations can help defray medical costs to eligible patients
- BRAND QUALITIES
- Battle of the biologics
- The rub on rubs
- OTC remedies’ contrasting arthritis approaches
- INNOVATION AND INNOVATORS
- Creams resonate with patients
- Functional beverages, easy-to-open lids
- Future pharmaceuticals?
- Pegloticase
- Tocilizumab
- Ustekinumab
- Oral small-molecule drugs
- NATURAL PRODUCT DATA
- A look at glucosamine and chondroitin supplements
- Recent studies show mixed results
- Natural channel sales flat
- Figure 4: Natural product supermarket retail sales of glucosamine, glucosamine formulas and chondroitin, at current prices, 2006-08
- Figure 5: Natural product supermarket retail sales of glucosamine, glucosamine formulas and chondroitin, at inflation-adjusted prices, 2006-08
- Implications
- ADVERTISING AND PROMOTION
- OVERVIEW
- Pharmaceutical adspend down again in 2008
- Figure 6: Pharmaceutical DTC advertisement spending, 2003-08
- Pharmaceutical cross-promotion
- Web advertising
- Enbrel
- Orencia
- Celebrex
- Aleve
- TV ads
- Humira
- Figure 7: Abbott Labs/Humira television ad, 2008
- Orencia
- Figure 8: Bristol-Myers Squibb/Orencia television ad, 2009
- Castiva
- Figure 9: Humco Holding Group, Inc./Castiva television ad, 2008
- Celebrex
- Figure 10: Pfizer/Celebrex television ad, 2009
- Enbrel
- Figure 11: Wyeth (Pfizer)-Amgen/Enbrel television ad, 2008
- RAinsider
- Figure 12: Wyeth (Pfizer)-Amgen/RAinsider television ad, 2008
- ARTHRITIS SUFFERERS
- Key points
- Arthritis sufferers
- Figure 13: Incidence of arthritis and other arthritic ailments, by gender and age, February 2009
- Figure 14: Incidence of osteoarthritis and rheumatoid arthritis, by gender and age, July 2007-September 2008
- Location of suffering
- Figure 15: Location of arthritis and other arthritic ailments, by gender and age, February 2009
- Symptom severity
- Figure 16: Severity of osteoarthritis, rheumatoid arthritis, or any arthritis, by gender and age, July 2007-September 2008
- CURRENT TREATMENT APPROACHES
- Key points
- OTC remedies top treatment methods, alternative options close behind
- Less commonly used methods offer possibilities for treatment development
- Figure 17: Current treatment methods for arthritis, by gender and age, February 2009
- Figure 18: Current treatment methods for arthritis, by HH income, February 2009
- MEDICATIONS
- Key points
- OTC vs. Rx
- Figure 19: Use of Rx and OTC medications for osteoarthritis, rheumatoid arthritis, or any arthritis, by gender and age, July 2007-September 2008
- Figure 20: Use of Rx and OTC medications for osteoarthritis, rheumatoid arthritis, or any arthritis, by HH income, July 2007-September 2008
- Use of headache/pain relievers, wraps/liquids/rubs
- Figure 21: Use of headache/pain relievers for arthritis or rheumatism, by gender and age, July 2007-September 2008
- Figure 22: Use of headache/pain relievers for arthritis or rheumatism, by HH income, July 2007-September 2008
- Figure 23: Use of pain relieving rubs/liquids/wraps for arthritic pain, by gender and age, July 2007-September 2008
- Figure 24: Use of pain relieving rubs/liquids for arthritic pain, by HH income, July 2007-September 2008
- PREFERENTIAL TREATMENT AND PREVENTION METHODS
- Key points
- Treatment method interest
- Figure 25: Somewhat/very interested in potential methods for treating arthritis, by gender, February 2009
- Preferred prevention methods
- Figure 26: Steps taken to prevent/delay arthritis, February 2009
- WHERE TO TURN FOR ARTHRITIS INFORMATION
- Key points
- Preferred professional sources for arthritis information
- Figure 27: Preferred professional sources for arthritis information, by gender and age, February 2009
- Other people and media as information sources
- Figure 28: Sources for healthcare information, by type of arthritis, July 2007-September 2008
- Figure 29: Preferred alternate sources for arthritis information, by gender and age, February 2009
- Affluence impacts health source reliance
- Figure 30: Select sources for arthritis information, by HH income, February 2009
- Consulting health professionals
- Figure 31: Types of healthcare professionals consulted in the last 12 months, by type of arthritis, July 2007-September 2008
- ATTITUDES AND MOTIVATIONS
- Key points
- Attitudes towards arthritis
- Figure 32: Attitudes towards arthritis, by gender and age, February 2009
- Activity limitations
- Figure 33: Activities limited by arthritis, by gender and age, February 2009
- RACE AND HISPANIC ORIGIN
- Key points
- Arthritis sufferers
- Figure 34: Incidence of arthritis and other arthritic ailments, by race/Hispanic origin, February 2009
- Location of suffering
- Figure 35: Location of arthritis and other arthritic ailments, by race/Hispanic origin, February 2009
- Symptom severity
- Figure 36: Severity of osteoarthritis, rheumatoid arthritis, or any arthritis, by race/Hispanic origin, July 2007-September 2008
- Alternative methods key in treatment
- Figure 37: Current treatment methods for arthritis, by race/Hispanic origin, February 2009
- Figure 38: Use of Rx and OTC medications for osteoarthritis, rheumatoid arthritis, or any arthritis, by race/Hispanic origin, July 2007-September 2008
- Preferred sources for arthritis information
- Figure 39: Types of healthcare professionals consulted in the last 12 months, by race/Hispanic origin, July 2007-September 2008
- APPENDIX: OTHER USEFUL CONSUMER TABLES
- Preferred sources for arthritis information
- Figure 40: Preferred sources for arthritis information, by HH income, February 2009
- Attitudes and motivations
- Figure 41: Attitudes towards arthritis, by HH income, February 2009
- Figure 42: Activities limited by arthritis, by HH income, February 2009
- Incidence and treatment
- Figure 43: Incidence of osteoarthritis and rheumatoid arthritis, by race/Hispanic origin, July 2007-September 2008
- Figure 44: Use of headache/pain relievers for arthritis or rheumatism, by race/Hispanic origin, July 2007-September 2008
- Figure 45: Use of pain relieving rubs/liquids/wraps, and use for arthritis, by race/Hispanic origin, July 2007-September 2008
- APPENDIX: TRADE ASSOCIATIONS
AbstractGiven the results of Mintel’s analysis of the Experian Simmons NCS/NHCS and the results of its own exclusive consumer survey, ample opportunity exists for further arthritis remedy marketing in drug store aisles.
The Experian Simmons NCS/NHCS reveals that pharmacists have a much more significant role among those with some type of arthritis than those without as an arthritis information source; some 25% of those with any type of arthritis say they have consulted with a pharmacist in the last 12 months. Furthermore, another 16% of arthritic respondents to Mintel’s exclusive survey rate pharmacists as a very good source of arthritis information.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
